Market Research Logo

Digital Pathology Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025

Digital Pathology Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025

Future Market Insights (FMI) offers a 10-year forecast of the global digital pathology market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 11.4% during the forecast period. This study provides insights regarding the market dynamics and trends in all seven regions that are expected to influence the current market environment and future status of the global digital pathology market over the forecast period.

Report Description

This report examines the global digital pathology market for the period 2015–2025, with the primary objective being to offer key insights on developments in the global digital pathology market, that are significantly helping to provide more integrated and digitised platform for the healthcare service providers by making the process of sharing slides across the health care sector mush easier.

The global digital pathology market report begins by defining digital pathology systems and the various components such as scanners, software and services that make up the whole package. It also lists the various end users opting for digital pathology systems, followed by an overview section, along with its parent market. Overview section includes FMI’s analysis of key trends, drivers, restraints and opportunities estimated to influence growth of the global digital pathology market over the forecast period. Impact analysis of key growth drivers and restraints based on weighted average model has been analysed to better equip customers and readers with region-specific trends, drivers, restraints and market insights.

Major factors driving growth of the global digital pathology market include increasing spending on cancer diagnostics and monitoring, increasing spending on healthcare IT and collaborative approach between pathologists and cloud service providers to facilitate faster decision making. Furthermore, increasing demand for image analysis software and personalised medicine has triggered growth of global digital pathology market. Research indicates that there is growing need for integrated modules of digital pathology, which enables better interoperability reliable outcome to pathologists. Secondly, there is growing need for automation in diagnostic procedures, starting from sample collection to final diagnosis, and this is estimated to further fuel demand for digital pathology systems for application in research laboratories and diagnostic laboratories. However, factors such as high capital cost for implementing digital pathology systems and stringent regulatory guidance for the use of digital pathology systems in primary diagnosis are factors hampering growth of the digital pathology market.

The global digital pathology market is segmented based on the basis of product type into hardware (scanners), software and services. Scanners segment is further sub-segmented into fluorescent scanners and bright field scanners. Scanners segment is further sub-segment into fluorescent digital pathology scanners and bright field digital pathology scanners. The software segment is further sub-segmented into image analysis and digital pathology information systems. On the basis of deployment mode, the image analysis and digital pathology information systems sub-segments are categorized as on-premise delivery and cloud based delivery solutions. The services segment is further sub-segmented into installation & integration services, consulting services and maintenance services. On the basis of end user, the market is segmented into hospitals, diagnostic laboratories and research centres. A detailed analysis of all the categories of end users has been provided in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

The report analyses the market based on digital pathology screening services such as haematology, chemical pathology, histopathology and medical microbiology. A thorough analysis, along with the market attractiveness index of each of these categories, has been provided in the report.

In the above sections - by product, end user, pathology screening services and region - we evaluate the present scenario and future growth prospects of the global digital pathology market for the period 2015 - 2025. We have considered 2014 as the base year and provided data for the forecast period, i.e. 2015-2025.

The next section of report highlights the digital pathology market by region. It provides the market outlook for 2015-2025 and sets the forecast within the context of the global digital pathology market. The study discusses key regional trends, drivers and restraints contributing to growth of digital pathology market, worldwide. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa.

To ascertain size of the global digital pathology (devices) market, we have considered the revenue generated from the sale of digital pathology software and scanners. The forecast presented here assesses total revenue generated across the digital pathology market, globally over the forecast period. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the digital pathology market is expected to develop in the future. Given the characteristics of the market, we have triangulated the outcome on the basis of supply-side and demand-side perspective, and downstream industry and economic envelope.

It is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse based on key parameters, such as Year-On-Year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities available in the market.

The global digital pathology market has been segmented in terms of products, pathology screening services, end users and regions, are analysed on the basis of their respective Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the global market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of digital pathology market.

To understand key growth segments in terms of growth, Future Market Insights developed the digital pathology market ‘Attractiveness Index’. The resulting index helps providers to identify real market opportunities and take informed decisions.

In the final section of the report, we offer the ‘Competitive Landscape’ section to provide report audiences with a dashboard view and to examine the key differentiators among competitor firms. Key categories of providers covered in the report are digital pathology scanners, software and service providers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the digital pathology value chain. This section also includes market strategies and SWOT analysis of the key players in the market.

Detailed profiles of digital pathology companies included are in the scope of the report to evaluate their long-term and short-term strategies. Key players in the market include:

Perkin Elmer, Inc.,
MedImmune, LLC (AstraZeneca),
Sectra AB
Koninklijke Philips N.V
GE Healthcare
Inspirata Co.
Ventana Medical Systems, Inc.
Leica Biosystems
3D-Histech Ltd.
Hamamatsu Photonics, K.K.
Digipath Co.
ZEISS
Olympus Corporation
Yokogawa Electronic Corporation.

Key Segments Covered

By Product
Scanner
Bright Field Scanner
Fluorescence Scanner
Software
Image Analysis Platform
On-premises Delivery
Cloud-based Delivery
Digital Pathology Information Systems
On-premises Delivery
Cloud-based Delivery
Services
Installation and Integration
Maintenance Services
Consulting Services
By End Use
Hospital
500+ Beds
200–499 Beds
Less than 200 Beds
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Research Centers
By Pathology Screening Services
Hematology
Chemical Pathology
Histopathology
Medical Microbiology"


1. Digital Pathology Market - Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Digital Pathology Market Overview
4.1. Introduction
4.1.1. Digital Pathology Market Definition
4.1.2. Digital Pathology Market Taxonomy
4.2. Digital Pathology Parent Market Overview
4.3. Global Digital Pathology Market Forecast, 2015–2025
4.3.1. Digital Pathology Market Size (Value) Forecast
4.3.1.1. Y-o-Y Growth Projections
4.3.1.2. Absolute $ Opportunity
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Pathology Market Trends
4.6. Regulatory Scenario
4.6.1. US
4.6.2. Canada
4.6.3. Europe
4.7. Primary (KOL) Outlooks
4.8. Attributes of cloud services
4.9. Industry life cycle and Competition Strategies
4.10. Consumer Adoption Process: Digital Pathology
4.10.1. North America and Europe
4.10.2. APAC and MEA
4.11. Pricing Analysis: Digital Pathology Systems
4.12. Commercial progress of digital pathology
4.12.1. Bottom Line of digital pathology installation
4.13. Global Digital Pathology Installed Base Scenario
5. Global Digital Pathology Market Analysis, By Product Type
5.1. Introduction
5.1.1. Global Digital Pathology Market Snapshot By Product Type
5.1.2. Y-o-Y Growth Comparison, By Product Type
5.1.3. Basis Point Share (BPS) Analysis, By Product Type
5.2. Digital Pathology Market Forecast By Product Type
5.2.1. Scanners
5.2.1.1. Whole Slide Imaging System
5.2.1.1.1. Bright Field Scanner
5.2.1.1.1.1. Absolute $ Opportunity
5.2.1.1.1.2. Market Value Forecast, By Region
5.2.1.1.2. Fluorescence Scanner
5.2.1.1.2.1. Absolute $ Opportunity
5.2.1.1.2.2. Market Value Forecast, By Region
5.2.2. Software
5.2.2.1. Image Analysis Platform
5.2.2.1.1. On-Premises Delivery
5.2.2.1.1.1. Absolute $ Opportunity
5.2.2.1.1.2. Market Value Forecast, By Region
5.2.2.2. Cloud Based Delivery
5.2.2.2.1. Absolute $ Opportunity
5.2.2.2.2. Market Value Forecast, By Region
5.2.2.3. Digital Pathology Information System
5.2.2.3.1. On-Premises Delivery
5.2.2.3.1.1. Absolute $ Opportunity
5.2.2.3.1.2. Market Value Forecast, By Region
5.2.2.3.2. Cloud Based Delivery
5.2.2.3.2.1. Absolute $ Opportunity
5.2.2.3.2.2. Market Value Forecast, By Region
5.2.3. Services
5.2.3.1. Installation and Integration
5.2.3.1.1. Absolute $ Opportunity
5.2.3.1.2. Market Value Forecast, By Region
5.2.3.2. Maintenance Services
5.2.3.2.1. Absolute $ Opportunity
5.2.3.2.2. Market Value Forecast, By Region
5.2.3.3. Consulting Services
5.2.3.3.1. Absolute $ Opportunity
5.2.3.3.2. Market Value Forecast, By Region
5.2.4. Market Attractiveness Analysis, By Product
6. Global Digital Pathology Market Analysis, By End Users
6.1. Introduction
6.1.1. Global Digital Pathology Market Snapshot By End User
6.1.2. Primary Outlook On the End User Segment
6.1.3. Y-o-Y Growth Comparison, By End Users
6.1.4. Basis Point Share (BPS) Analysis, By End Users
6.2. Market Forecast By End Users
6.2.1. Hospitals
6.2.1.1. Absolute $ Opportunity
6.2.1.2. Market Value Forecast, By Region
6.2.2. Diagnostic Labs
6.2.2.1. Absolute $ Opportunity
6.2.2.2. Market Value Forecast, By Region
6.2.3. Research Centers
6.2.3.1. Absolute $ Opportunity
6.2.3.2. Market Value Forecast, By Region
6.3. Market Attractiveness Analysis, By End Users
7. Global Digital Pathology Market Analysis, By Pathology Screening Services
7.1. Introduction
7.1.1. Global Digital Pathology Market Snapshot By Pathology Screening Services
7.1.2. Y-o-Y Growth Comparison, By Pathology Screening Services
7.1.3. Basis Point Share (BPS) Analysis, By Pathology Screening Services
7.1.4. Market Attractiveness Analysis, By Pathology Screening Services
7.2. Pricing Analysis: Digital Pathology Screening Services
7.3. Market Forecast By Pathology Screening Services
7.3.1. Chemical Pathology
7.3.1.1. Absolute $ Opportunity
7.3.1.2. Market Value Forecast, By Region
7.3.2. Haematology
7.3.2.1. Absolute $ Opportunity
7.3.2.2. Market Value Forecast, By Region
7.3.3. Histopathology
7.3.3.1. Absolute $ Opportunity
7.3.3.2. Market Value Forecast, By Region
7.3.4. Medical Microbiology
7.3.4.1. Absolute $ Opportunity
7.3.4.2. Market Value Forecast, By Region
8. Global Digital Pathology Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Basis Point Share (BPS) Analysis, By Region
8.2. Market Forecast By Region
8.2.1. North America Market Value Forecast
8.2.2. Latin America Market Value Forecast
8.2.3. Asia Pacific Excl. Japan Market Value Forecast
8.2.4. Western Europe Market Value Forecast
8.2.5. Eastern Europe Market Value Forecast
8.2.6. Middle East & Africa Market Value Forecast
8.2.7. Japan Market Value Forecast
8.3. Regional Attractiveness Analysis
9. North America Digital Pathology Market Analysis
9.1. Introduction
9.1.1. Y-o-Y Growth Projections, By Country
9.1.2. Basis Point Share (BPS) Analysis, By Country
9.1.3. Key Trends
9.2. North America Digital Pathology Market Forecast
9.2.1. Market Value Forecast By Country
9.2.1.1. U.S. Absolute $ Opportunity
9.2.1.2. Canada Absolute $ Opportunity
9.2.2. Market Value Forecast By Product
9.2.2.1. Scanners
9.2.2.1.1. Whole Slide Imaging System
9.2.2.1.1.1. Bright Field Scanner
9.2.2.1.1.2. Fluorescence Scanner
9.2.2.2. Software
9.2.2.2.1. Image Analysis Platform
9.2.2.2.1.1. On-Premises Delivery
9.2.2.2.1.2. Cloud Based Delivery
9.2.2.2.2. Digital Pathology Information System
9.2.2.2.2.1. On-Premises Delivery
9.2.2.2.2.2. Cloud Based Delivery
9.2.2.3. Services
9.2.2.3.1. Installation and Integration
9.2.2.3.2. Maintenance Services
9.2.2.3.3. Consulting Services
9.2.3. Market Value Forecast By End Users
9.2.3.1. Hospitals
9.2.3.1.1. 500+ Beds
9.2.3.1.2. 200-499 Beds
9.2.3.1.3. Less than 200 Beds
9.2.3.2. Diagnostic labs
9.2.3.2.1. Private Laboratories
9.2.3.2.2. Public Laboratories
9.2.3.3. Research Centers
9.2.4. Market Value Forecast By Pathology Screening Services
9.2.4.1. Hematology
9.2.4.2. Chemical Pathology
9.2.4.3. Histopathology
9.2.4.4. Medical Microbiology
9.2.5. Market Attractiveness Analysis
9.2.5.1. By Country
9.2.5.2. By Product
9.2.5.3. By Pathology Screening Services
9.2.5.4. By End Users
9.2.5.5. Drivers & Restraints: Impact Analysis
10. Latin America Digital Pathology Market Analysis
10.1. Introduction
10.1.1. Key Trends
10.1.2. Y-o-Y Growth Projections, By Country
10.1.3. Basis Point Share (BPS) Analysis, By Country
10.2. Latin America Digital Pathology Market Forecast
10.2.1. Market Value Forecast By Country
10.2.1.1. Mexico Absolute $ Opportunity
10.2.1.2. Brazil Absolute $ Opportunity
10.2.1.3. Rest of LATAM Absolute $ Opportunity
10.2.2. Market Value Forecast By Product
10.2.2.1. Scanners
10.2.2.1.1. Whole Slide Imaging System
10.2.2.1.1.1. Bright Field Scanner
10.2.2.1.1.2. Fluorescence Scanner
10.2.2.2. Software
10.2.2.2.1. Image Analysis Platform
10.2.2.2.1.1. On-Premises Delivery
10.2.2.2.1.2. Cloud Based Delivery
10.2.2.2.2. Digital Pathology Information System
10.2.2.2.2.1. On-Premises Delivery
10.2.2.2.2.2. Cloud Based Delivery
10.2.2.3. Services
10.2.2.3.1. Installation and Integration
10.2.2.3.2. Maintenance Services
10.2.2.3.3. Consulting Services
10.2.3. Market Value Forecast By End Users
10.2.3.1. Hospitals
10.2.3.1.1. 500+ Beds
10.2.3.1.2. 200-499 Beds
10.2.3.1.3. Less than 200 Beds
10.2.3.2. Diagnostic labs
10.2.3.2.1. Private Laboratories
10.2.3.2.2. Public Laboratories
10.2.3.3. Research Centers
10.2.4. Market Value Forecast By Pathology Screening Services
10.2.4.1. Hematology
10.2.4.2. Chemical Pathology
10.2.4.3. Histopathology
10.2.4.4. Medical Microbiology
10.2.5. Market Attractiveness Analysis
10.2.5.1. By Country
10.2.5.2. By Product
10.2.5.3. By Pathology Screening Services
10.2.5.4. By End Users
10.2.5.5. Drivers & Restraints: Impact Analysis
11. Western Europe Digital Pathology Market Analysis
11.1. Introduction
11.1.1. Y-o-Y Growth Projections, By Country / Region
11.1.2. Basis Point Share (BPS) Analysis, By Country / Region
11.1.3. Key Regulations
11.1.4. Key Trends
11.2. Western Europe Market Forecast
11.2.1. Market Value Forecast By Country/Region
11.2.1.1. Germany Absolute $ Opportunity
11.2.1.2. France Absolute $ Opportunity
11.2.1.3. U.K. Absolute $ Opportunity
11.2.1.4. Spain Absolute $ Opportunity
11.2.1.5. Italy Absolute $ Opportunity
11.2.1.6. Nordic Absolute $ Opportunity
11.2.1.7. BENELUX Absolute $ Opportunity
11.2.1.8. Rest of Western Europe Absolute $ Opportunity
11.2.2. Market Value Forecast By Product
11.2.2.1. Scanners
11.2.2.1.1. Whole Slide Imaging System
11.2.2.1.1.1. Bright Field Scanner
11.2.2.1.1.2. Fluorescence Scanner
11.2.2.2. Software
11.2.2.2.1. Image Analysis Platform
11.2.2.2.1.1. On-Premises Delivery
11.2.2.2.1.2. Cloud Based Delivery
11.2.2.2.2. Digital Pathology Information System
11.2.2.2.2.1. On-Premises Delivery
11.2.2.2.2.2. Cloud Based Delivery
11.2.2.3. Services
11.2.2.3.1. Installation and Integration
11.2.2.3.2. Maintenance Services
11.2.2.3.3. Consulting Services
11.2.3. Market Value Forecast By End Users
11.2.3.1. Hospitals
11.2.3.1.1. 500+ Beds
11.2.3.1.2. 200-499 Beds
11.2.3.1.3. Less than 200 Beds
11.2.3.2. Diagnostic labs
11.2.3.2.1. Private Laboratories
11.2.3.2.2. Public Laboratories
11.2.3.3. Research Centers
11.2.4. Market Value Forecast By Pathology Screening Services
11.2.4.1. Hematology
11.2.4.2. Chemical Pathology
11.2.4.3. Histopathology
11.2.4.4. Medical Microbiology
11.2.5. Market Attractiveness Analysis
11.2.5.1. By Country
11.2.5.2. By Product
11.2.5.3. By Pathology Screening Services
11.2.5.4. By End Users
11.2.5.5. Drivers & Restraints: Impact Analysis
12. Eastern Europe Digital Pathology Market Analysis
12.1. Introduction
12.1.1. Y-o-Y Growth Projections, By Country / Region
12.1.2. Basis Point Share (BPS) Analysis, By Country / Region
12.1.3. Key Regulations
12.1.4. Key Trends
12.2. Eastern Europe Market Forecast
12.2.1. Market Value Forecast By Country/Region
12.2.1.1. Russia Absolute $ Opportunity
12.2.1.2. Poland Absolute $ Opportunity
12.2.1.3. Rest of Eastern Europe Absolute $ Opportunity
12.2.2. Market Value Forecast By Product
12.2.2.1. Scanners
12.2.2.1.1. Whole Slide Imaging System
12.2.2.1.1.1. Bright Field Scanner
12.2.2.1.1.2. Fluorescence Scanner
12.2.2.2. Software
12.2.2.2.1. Image Analysis Platform
12.2.2.2.1.1. On-Premises Delivery
12.2.2.2.1.2. Cloud Based Delivery
12.2.2.2.2. Digital Pathology Information System
12.2.2.2.2.1. On-Premises Delivery
12.2.2.2.2.2. Cloud Based Delivery
12.2.2.3. Services
12.2.2.3.1. Installation and Integration
12.2.2.3.2. Maintenance Services
12.2.2.3.3. Consulting Services
12.2.3. Market Value Forecast By End Users
12.2.3.1. Hospitals
12.2.3.1.1. 500+ Beds
12.2.3.1.2. 200-499 Beds
12.2.3.1.3. Less than 200 Beds
12.2.3.2. Diagnostic labs
12.2.3.2.1. Private Laboratories
12.2.3.2.2. Public Laboratories
12.2.3.3. Research Centers
12.2.4. Market Value Forecast By Pathology Screening Services
12.2.4.1. Hematology
12.2.4.2. Chemical Pathology
12.2.4.3. Histopathology
12.2.4.4. Medical Microbiology
12.2.5. Market Attractiveness Analysis
12.2.5.1. By Country
12.2.5.2. By Product
12.2.5.3. By Pathology Screening Services
12.2.5.4. By End Users
12.2.5.5. Drivers & Restraints: Impact Analysis
13. APEJ Digital Pathology Market Analysis
13.1. Introduction
13.1.1. Y-o-Y Growth Projections, By Country
13.1.2. Basis Point Share (BPS) Analysis, By Country / Region
13.1.3. Key Regulations
13.1.4. Key Trends
13.2. APEJ Market Forecast
13.2.1. Market Value Forecast By Country/Region
13.2.1.1. China Absolute $ Opportunity
13.2.1.2. India Absolute $ Opportunity
13.2.1.3. ASEAN Absolute $ Opportunity
13.2.1.4. ANZ Absolute $ Opportunity
13.2.1.5. Rest of APEJ Absolute $ Opportunity
13.2.2. Market Value Forecast By Product
13.2.2.1. Scanners
13.2.2.1.1. Whole Slide Imaging System
13.2.2.1.1.1. Bright Field Scanner
13.2.2.1.1.2. Fluorescence Scanner
13.2.2.2. Software
13.2.2.2.1. Image Analysis Platform
13.2.2.2.1.1. On-Premises Delivery
13.2.2.2.1.2. Cloud Based Delivery
13.2.2.2.2. Digital Pathology Information System
13.2.2.2.2.1. On-Premises Delivery
13.2.2.2.2.2. Cloud Based Delivery
13.2.2.3. Services
13.2.2.3.1. Installation and Integration
13.2.2.3.2. Maintenance Services
13.2.2.3.3. Consulting Services
13.2.3. Market Value Forecast By End Users
13.2.3.1. Hospitals
13.2.3.1.1. 500+ Beds
13.2.3.1.2. 200-499 Beds
13.2.3.1.3. Less than 200 Beds
13.2.3.2. Diagnostic labs
13.2.3.2.1. Private Laboratories
13.2.3.2.2. Public Laboratories
13.2.3.3. Research Centers
13.2.4. Market Value Forecast By Pathology Screening Services
13.2.4.1. Hematology
13.2.4.2. Chemical Pathology
13.2.4.3. Histopathology
13.2.4.4. Medical Microbiology
13.2.5. Market Attractiveness Analysis
13.2.5.1. By Country
13.2.5.2. By Product
13.2.5.3. By Pathology Screening Services
13.2.5.4. By End Users
13.2.5.5. Drivers & Restraints: Impact Analysis
14. Japan Digital Pathology Market Analysis
14.1. Introduction
14.1.1. Y-o-Y Growth Projections, By Country / Region
14.1.2. Key Regulations
14.1.3. Key Trends
14.2. Japan Market Forecast
14.2.1. Market Value Forecast By Product
14.2.1.1. Scanners
14.2.1.1.1. Whole Slide Imaging System
14.2.1.1.1.1. Bright Field Scanner
14.2.1.1.1.2. Fluorescence Scanner
14.2.1.2. Software
14.2.1.2.1. Image Analysis Platform
14.2.1.2.1.1. On-Premises Delivery
14.2.1.2.1.2. Cloud Based Delivery
14.2.1.2.2. Digital Pathology Information System
14.2.1.2.2.1. On-Premises Delivery
14.2.1.2.2.2. Cloud Based Delivery
14.2.1.3. Services
14.2.1.3.1. Installation and Integration
14.2.1.3.2. Maintenance Services
14.2.1.3.3. Consulting Services
14.2.2. Market Value Forecast By End Users
14.2.2.1. Hospitals
14.2.2.1.1. 500+ Beds
14.2.2.1.2. 200-499 Beds
14.2.2.1.3. Less than 200 Beds
14.2.2.2. Diagnostic labs
14.2.2.2.1. Private Laboratories
14.2.2.2.2. Public Laboratories
14.2.2.3. Research Centers
14.2.3. Market Value Forecast By Pathology Screening Services
14.2.3.1. Hematology
14.2.3.2. Chemical Pathology
14.2.3.3. Histopathology
14.2.3.4. Medical Microbiology
14.2.4. Market Attractiveness Analysis
14.2.4.1. By Country
14.2.4.2. By Product
14.2.4.3. By Pathology Screening Services
14.2.4.4. By End Users
14.2.4.5. Drivers & Restraints: Impact Analysis
15. Middle East & Africa Digital Pathology Market Analysis
15.1. Introduction
15.1.1. Y-o-Y Growth Projections, By Country / Region
15.1.2. Basis Point Share (BPS) Analysis, By Country / Region
15.1.3. Key Regulations
15.1.4. Key Trends
15.2. Middle East & Africa Market Forecast
15.2.1. Market Value Forecast By Country/Region
15.2.1.1. GCC Absolute $ Opportunity
15.2.1.2. N. Africa Absolute $ Opportunity
15.2.1.3. S. Africa Absolute $ Opportunity
15.2.1.4. Rest of MEA Absolute $ Opportunity
15.2.2. Market Value Forecast By Product
15.2.2.1. Scanners
15.2.2.1.1. Whole Slide Imaging System
15.2.2.1.1.1. Bright Field Scanner
15.2.2.1.1.2. Fluorescence Scanner
15.2.2.2. Software
15.2.2.2.1. Image Analysis Platform
15.2.2.2.1.1. On-Premises Delivery
15.2.2.2.1.2. Cloud Based Delivery
15.2.2.2.2. Digital Pathology Information System
15.2.2.2.2.1. On-Premises Delivery
15.2.2.2.2.2. Cloud Based Delivery
15.2.2.3. Services
15.2.2.3.1. Installation and Integration
15.2.2.3.2. Maintenance Services
15.2.2.3.3. Consulting Services
15.2.3. Market Value Forecast By End Users
15.2.3.1. Hospitals
15.2.3.1.1. 500+ Beds
15.2.3.1.2. 200-499 Beds
15.2.3.1.3. Less than 200 Beds
15.2.3.2. Diagnostic labs
15.2.3.2.1. Private Laboratories
15.2.3.2.2. Public Laboratories
15.2.3.3. Research Centers
15.2.4. Market Value Forecast By Pathology Screening Services
15.2.4.1. Hematology
15.2.4.2. Chemical Pathology
15.2.4.3. Histopathology
15.2.4.4. Medical Microbiology
15.2.5. Market Attractiveness Analysis
15.2.5.1. By Country
15.2.5.2. By Product
15.2.5.3. By Pathology Screening Services
15.2.5.4. By End Users
15.2.5.5. Drivers & Restraints: Impact Analysis
16. Competition Landscape
16.1. Competition Dashboard
16.2. Company Profiles
16.2.1. Perkin Elmer, Inc.
16.2.2. Definiens AG
16.2.3. Sectra ABss
16.2.4. Koninklijke Philips N.V
16.2.5. GE Healthcare
16.2.6. Inspirata Co.
16.2.7. Ventana Medical Systems, Inc.
16.2.8. Leica Biosystems
16.2.9. 3D-Histech Ltd
16.2.10. Hamamatsu Photonics, K.K.
16.2.11. Digipath Co.
16.2.12. ZEISS
16.2.13. Olympus Corporation
16.2.14. Yokogawa Electronic Corporation
16.2.15. Quorum Technologies Inc.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report